Alex Nowbar (@alexnowbar) 's Twitter Profile
Alex Nowbar

@alexnowbar

Cardiology Registrar

ID: 1034869079167918080

calendar_today29-08-2018 18:23:10

630 Tweet

675 Followers

281 Following

CVCTcardiobrief (@cvctcardiobrief) 's Twitter Profile Photo

A Pragmatic Trial isn’t just a Simple Trial: An Interview with Colin Baigent about ADAPTABLE cvctcardiobrief.com/a-pragmatic-tr…

Rasha Al-Lamee (@rallamee) 's Twitter Profile Photo

Thank you to @HelenRoutledge2, Andy Epstein and the team at Worcestershire Acute Hospitals NHS Trust for randomising the 100th patient into ORBITA-2. Amazing work! Christopher Rajkumar Alex Nowbar Michael Foley

Thank you to @HelenRoutledge2, Andy Epstein and the team at Worcestershire Acute Hospitals NHS Trust for randomising the 100th patient into ORBITA-2. Amazing work! <a href="/rajkumar_chris/">Christopher Rajkumar</a> <a href="/AlexNowbar/">Alex Nowbar</a> <a href="/MikeFoley89/">Michael Foley</a>
CVCTcardiobrief (@cvctcardiobrief) 's Twitter Profile Photo

The Lowdown on the Left Atrial Appendage Occlusion Study III: an Interview with Gerhard Hindricks and Thomas F. Deering cvctcardiobrief.com/the-lowdown-on…

Henry Seligman (@henselig) 's Twitter Profile Photo

Our latest coronary physiology paper online now EuroIntervention. You must have heard or read before that "flow in the right coronary artery can be predominantly systolic". True, a myth or a case report bias? We investigated this formally in the large IDEAL study dataset. 1/n

Our latest coronary physiology paper online now <a href="/EuroInterventio/">EuroIntervention</a>. 

You must have heard or read before that "flow in the right coronary artery can be predominantly systolic". True, a myth or a case report bias? We investigated this formally in the large IDEAL study dataset. 1/n
Boback Ziaeian 🤦🏻‍♂️ (@boback) 's Twitter Profile Photo

Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding ⁦Rasha Al-Lamee⁩ ⁦Prof Darrel Francis ☺ Mk CardioFellows Great Again⁩ ⁦Alex Nowbar⁩ link.springer.com/article/10.100…

Prof Darrel Francis ☺ Mk CardioFellows Great Again (@profdfrancis) 's Twitter Profile Photo

Calling everyone in UK that cares about the NHS. When a drug goes off patent, it becomes cheap, yeh? No. If there is only one manufacturer they can screw us over for millions. Please sign Karim Meeran's petition to the government which will fix this. petition.parliament.uk/petitions/5937…

Calling everyone in UK that cares about the NHS.

When a drug goes off patent, it becomes cheap, yeh?

No. 

If there is only one manufacturer they can screw us over for millions.

Please sign Karim Meeran's petition to the government which will fix this.

petition.parliament.uk/petitions/5937…
James Howard (@drjhoward) 's Twitter Profile Photo

Excited to say the SAMSON Trial's full data has now been published in JACC Journals. There is lots of interesting data, such as the remarkably similar timecourses of symptom onset and offset when starting and stopping statins and placebo jacc.org/doi/10.1016/j.…

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

ORBITA-2 will provide placebo-controlled data on the efficacy of PCI on symptoms in patients off antianginal medications. An ordinal clinical outcome scale for angina was designed in partnership with patients to be a relevant and inclusive primary outcome. eurointervention.pcronline.com/article/a-doub…

ORBITA-2 will provide placebo-controlled data on the efficacy of PCI on symptoms in patients off antianginal medications. An ordinal clinical outcome scale for angina was designed in partnership with patients to be a relevant and inclusive primary outcome. eurointervention.pcronline.com/article/a-doub…
Jacob de Wolff 🇳🇱🚲☕️ (@jfdwolff) 's Twitter Profile Photo

My best one? Auditing the use of continuous ECG monitoring on AMU. We've done this audit 3-4 times. Alex Nowbar Catherine Beattie Only when we implemented IT-based reminders, with buy-in from the head of the site operations team, did things start to improve.

Lindau Nobel Laureate Meetings (@lindaunobel) 's Twitter Profile Photo

The OphanTalent Academy #Sciathon project by Lindau Alumna Crina Samarghitean wants to connect orphan children all over the world with orphan rare diseases patients and the best researchers in the world. Help them by taking this survey: ow.ly/mpt450O2KsK